Search for a trial

A multi-center, randomized, double-blind, three-arm, 16 week, adaptive phase III clinical
study to investigate the efficacy and safety of LAS41008 vs LASW1835 and vs placebo in
patients with moderate to severe chronic plaque psoriasis

Primary Objective:The primary objectives of the study are to demonstrate:• Superiority of LAS41008 versus placebo based on the proportion of subjects achievingPASI 75 at week 16 (a 75% reduction in the Psoriasis Area and Severity Index, PASI,…